Insmed Incorporated

US$114.41As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:INSMHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR 24.26%
Div yield —
ROE (72.45%)
Biotechnology
Beta (5Y) 0.81
PE TTM —
TSR TTM (39.66%)
Mkt cap US$25.10B
ROIC (25.18%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$128
11.61%
(5.84%)
Hold 2|8|8|1|11
4Q25
1Q26
2Q26
3Q26
Earnings per share$
1.69
1.86
1.99
2.02
16.34%
28.44%
22.79%
16.67%
Revenue$B
2.347
2.293
2.232
2.183
5.71%
(0.45%)
(3.74%)
(5.39%)
Peers (US$25.10B)
Cap (US$)
PE
24.39B
61.55x
16.98B
20.78x
Capital
TTM
5Y
10Y
Leveragex
0.132
0.096
0.073
EBIT/Intx
5.804
0.665
0.699
Own earn%
58.45
(48.79)
(41.82)
Sh yield%
36.74
36.96
37.65
Owners
Insiders/Inst%
8.86
55.19
Short interest%
1.82
SBC / revenue%
5.72
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
7
Op margin range%
18–26
$1 testx
−0.1
Incr. ROIC%
29